cckinase, Inc.

Favorite  |  Set Home
E-mail: info@cckinase.com
Products > Apoptosis > Bcl-2 inhibitor > A-1331852 (A1331852, A 1331852)
A-1331852 (A1331852, A 1331852)
Product name : A-1331852 (A1331852, A 1331852)
Product No. : 20171225528
Price : 100mg/$675; 500mg/$1875
CAS : 
Bulk inquiry : 
←[Previous Product]              [Next Product]→
Online Inquiry         Email Us

  Details:
A-1331852 (CAS: 1430844-80-6) is an orally available BCL-XL selective inhibitor with a Ki of less than 10 pM.  BCL-XL-selective inhibitors have the potential to enhance the efficacy of docetaxel in solid tumors and avoid the exacerbation of neutropenia observed with navitoclax. A-1331852 may have potential as improved cancer therapeutics.

  Related Products :

AMG-176 (AMG176, AMG 176)
AMG-176 (AMG176, AMG 176)
Price: 10mg/$975, 100mg$4875

Mcl1-IN-1
Mcl1-IN-1
Price: 100mg, $975, 500mg/$2475

FX-1 (FX1, FX 1)
FX-1 (FX1, FX 1)
Price: 100mg/$475; 500mg/$1275

MIM1 (MIM 1; MIM-1; Inhibitor of Mcl-1)
MIM1 (MIM 1; MIM-1; Inhibitor of Mcl-1)
Price: 100mg, $1975, 500mg/$4475

UMI-77 (UMI77, UMI 77)
UMI-77 (UMI77, UMI 77)
Price: 100mg, $475, 500mg/$1275

ABT-263 (Navitoclax, ABT263)
ABT-263 (Navitoclax, ABT263)
Price: 500mg, $975

Spautin-1
Spautin-1
Price: 100mg, $475, 500mg/$1275

Mcl-IN-2
Mcl-IN-2
Price: 100mg, $675, 500mg/$1875

Online service

info@cckinase.com